Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Elife|September 30, 2025
Targeting chromatin remodeling complexes to treat uveal melanomaJonas A NilssonCell Cycle (Georgetown, Tex.)|April 27, 2004
Mnt: master regulator of the Max networkJonas A Nilsson, John L ClevelandOncogene|December 10, 2003
Myc pathways provoking cell suicide and cancerJonas A Nilsson, John L ClevelandImmunity|October 18, 2015
Deubiquitinase MYSM1 Regulates Innate Immunity through Inactivation of TRAF3 and TRAF6 ComplexesSwarupa Panda, Jonas A Nilsson, Nelson O GekaraCancer Prevention Research (Philadelphia, Pa.)|January 28, 2010
Chemoprevention of B-cell lymphomas by inhibition of the Myc target spermidine synthaseTachaZi Plym Forshell, Sara Rimpi, Jonas A NilssonBritish Journal of Haematology|November 25, 2017
Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancersMarkus Schick, Stefan Habringer, Jonas A Nilsson, et al.Nature Genetics|November 11, 2014
Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor typesNils J Fredriksson, Lars Ny, Jonas A Nilsson, et al.Journal of Plastic Surgery and Hand Surgery|January 25, 2019
Clinical, genetic and experimental studies of the Brooke-Spiegler (CYLD) skin tumor syndromeMattias K Andersson, Lars Kölby, Jonas A Nilsson, et al.Epigenetics|July 1, 2020
BET bromodomain inhibitor HMBA synergizes with MEK inhibition in treatment of malignant gliomaElisa Funck-Brentano, Dzeneta Vizlin-Hodzic, Jonas A Nilsson, et al.Life Science Alliance|June 24, 2020
Small molecule inhibitors and a kinase-dead expressing mouse model demonstrate that the kinase activity of Chk1 is essential for mouse embryos and cancer cellsSomsundar V Muralidharan, Lisa M Nilsson, Mattias F Lindberg, et al.Pageof 10